Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...

Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.

A new study suggests that semaglutide, the active ingredient in Ozempic, may help decrease liver fat, inflammation, and ...

Fat cells are also metabolically active and can cause a chronic state of inflammation in the part of the body where they ...

Semaglutide, which is traditionally a treatment for type 2 diabetes, was given to participants who had been diagnosed with a life-threatening form of liver disease called metabolic dysfunction ...

Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly ... Researchers chose to investigate semaglutide as a potential treatment because this class of drug helps reduce fat ...

director of the Stravitz-Sanyal Institute for Liver Disease and Metabolic Health at Virginia Commonwealth University in Richmond. “That is the goal of treatment.” Semaglutide, sold under the ...

Currently, there is only one FDA-approved treatment available ... “By treating both liver disease and its metabolic causes, semaglutide offers a promising new approach for millions of patients.” ...

semaglutide offers a promising new approach for millions of patients," Sanyal said. Currently, there is only one U.S. government-approved treatment available for fatty liver disease, Rezdiffra ...

Semaglutide, available under the brand names Ozempic and Wegovy, may help decrease the risk of major adverse cardiovascular ...

Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine. Semaglutide, which ...